Phase 3 study of AJG533 in patients with chronic constipatio
Phase 3
- Conditions
- Chronic constipation
- Registration Number
- JPRN-jRCT2080223008
- Lead Sponsor
- EA Pharma Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Patients with chronic constipation
Exclusion Criteria
Patients with known or suspected organic constipation
Patients with known or suspected symptomatic constipation or drug-induced constipation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of Spontaneous Bowel Movement<br>Change from baseline
- Secondary Outcome Measures
Name Time Method Complete Spontaneous Bowel Movement<br>Rate of Patients Experienced the First SBM within 24 Hours/ 48 Hours<br>SBM and CSBM Responder Rate<br>Time to the First SBM<br>Use of Rescue Medication<br>Stool Consistency Measured by Bristol Stool Form Scale